When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVS - Kodiak Sciences Fully Funded And Ready To Potentially Change Wet-AMD Treatment
Novartis AG
Kodiak Sciences (KOD) is a biotech that should be closely watched by investors. It had enacted an agreement with Baker Bros. Advisors to sell its future royalties for a particular drug. The drug included as part of the deal is known as KSI-301 for the treatment of retinal vascular disorders. The potential with this stock exists on the basis that the drug is being used to treat a variety of eye diseases. A pivotal study using KSI-301 already has been initiated and the company plans to initiate other pivotal studies for certain indications.